Avricore Health (AVCRF) Net Margin (2009 - 2026)

Avricore Health (AVCRF) has reported Net Margin for 17 consecutive years, with 544.66% the latest figure, recorded in Q2 2026.

• In Q2 2026, Net Margin rose 105511.0% year-over-year to 544.66%; the TTM figure through Jun 2026 stood at 740.82% (down 72906.0% YoY), while the FY2025 annual figure was 348.17%, down 33419.0% from the prior year.
• Net Margin rose to 544.66% in Q2 2026 per AVCRF's latest filing, from 1338.95% in the prior quarter.
• Across five years, Net Margin topped out at 14.99% in Q1 2024 and bottomed at 1599.78% in Q2 2025.
• Historically, Net Margin has averaged 325.24% across 5 years, with a median of 31.16% in 2022.
• Annual changes were most pronounced in 2025 — Net Margin tumbled 161004 bps — and 2026, when it surged 105511 bps.
• Avricore Health's Net Margin stood at 24.21% in 2022, then jumped by 121 bps to 5.14% in 2023, then plunged by 204 bps to 5.32% in 2024, then plunged by 25066 bps to 1338.95% in 2025, then surged by 59 bps to 544.66% in 2026.
• Business Quant data shows AVCRF's Net Margin at 544.66% in Q2 2026, 1338.95% in Q4 2025, and 1006.6% in Q3 2025.